Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Gynecologic Oncology
>
2016
>
27
>
4
Volume:
27
Issue:
4
1. Current status of brachytherapy in Korea: a national survey of radiation oncologists.
Page:e33—
2. Current status of brachytherapy in Korea: a national survey of radiation oncologists.
Page:e33—
3. Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO).
Page:e36—
4. Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO).
Page:e36—
5. Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio.
Page:e37—
6. Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio.
Page:e37—
7. Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer.
Page:e38—
8. Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer.
Page:e38—
9. Robotic single site versus robotic multiport hysterectomy in early endometrial cancer: a case control study.
Page:e39—
10. Robotic single site versus robotic multiport hysterectomy in early endometrial cancer: a case control study.
Page:e39—
11. Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma.
Page:e40—
12. Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma.
Page:e40—
13. Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer.
Page:e41—
14. Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer.
Page:e41—
15. Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in cervical cancer.
Page:e42—
16. Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in cervical cancer.
Page:e42—
17. Advances in diagnosis and treatment of metastatic cervical cancer.
Page:e43—
18. Advances in diagnosis and treatment of metastatic cervical cancer.
Page:e43—
19. Risk factor analysis for massive lymphatic ascites after laparoscopic retroperitonal lymphadenectomy in gynecologic cancers and treatment using intranodal lymphangiography with glue embolization.
Page:e44—
20. Risk factor analysis for massive lymphatic ascites after laparoscopic retroperitonal lymphadenectomy in gynecologic cancers and treatment using intranodal lymphangiography with glue embolization.
Page:e44—
